Seqens Seqens

X

Find the latest Drugs in Development and Pipeline Prospector News of Forty Seven.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Forty Seven
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
1490 O'Brien Drive Suite A Menlo Park, CA 94025
Telephone
Telephone
650-352-4150
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

Gilead gains Forty Seven’s investigational immuno-oncology therapy in multiple clinical studies, supporting its strategic focus in oncology as well as innovative pipeline.


Lead Product(s): Magrolimab

Therapeutic Area: Oncology Product Name: Undisclosed

Highest Development Status: Phase IIProduct Type: Large molecule

Partner/Sponsor/Collaborator: Gilead Sciences

Deal Size: $4,900.0 million Upfront Cash: $4,900.0 million

Deal Type: Acquisition March 02, 2020

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY